These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 16039826)
1. The use of topical 5% imiquimod during pregnancy: a case series. Einarson A; Costei A; Kalra S; Rouleau M; Koren G Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826 [No Abstract] [Full Text] [Related]
3. New treatments for genital warts less than ideal: abstract and commentary. Fife KH JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868 [No Abstract] [Full Text] [Related]
4. Management of difficult anogenital warts. Eggleton S; Tang A Sex Transm Infect; 1999 Dec; 75(6):449-50. PubMed ID: 10754962 [No Abstract] [Full Text] [Related]
5. FDA approval of imiquimod cream in treatment of STD warts. AIDS Patient Care STDS; 1997 Oct; 11(5):377-8. PubMed ID: 11361830 [No Abstract] [Full Text] [Related]
6. Topical imiquimod therapy for external anogenital warts in pregnant women. Audisio T; Roca FC; Piatti C Int J Gynaecol Obstet; 2008 Mar; 100(3):275-6. PubMed ID: 18035356 [No Abstract] [Full Text] [Related]
9. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions. Carrasco D; vander Straten M; Tyring SK J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280 [TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient. Gayed SL Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940 [TBL] [Abstract][Full Text] [Related]
14. The role of imiquimod 3.75% cream in the treatment of external genital warts. Berman B; Wolf J Skin Therapy Lett; 2012 Apr; 17(4):5-7. PubMed ID: 22491804 [TBL] [Abstract][Full Text] [Related]
15. Impetigo as an adverse effect of topical 5% imiquimod treatment for viral warts. Heng LW; Chandran NS Int J Dermatol; 2021 Jul; 60(7):909-910. PubMed ID: 33660286 [No Abstract] [Full Text] [Related]
16. Effect of imiquimod in anogenital warts from HIV-positive men. Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167 [TBL] [Abstract][Full Text] [Related]
17. Treatment of genital warts with an immune-response modifier (imiquimod). Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679 [TBL] [Abstract][Full Text] [Related]